Want to see MTLS full AI Analyst Report?
MTLS Stock Chart & Stats
$5.46
-$0.59(-7.31%)
At close: 4:00 PM EST
$5.46
-$0.59(-7.31%)
Day’s Range― - ―
52-Week Range$4.78 - $7.00
Previous CloseN/A
Volume181.37K
Average Volume (3M)165.28K
Market Cap
$422.92M
Enterprise Value$266.11M
Total Cash (Recent Filing)$132.95M
Total Debt (Recent Filing)$60.13M
Price to Earnings (P/E)36.5
Beta1.10
Next Earnings
Aug 27, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding59,067,184
10 Day Avg. Volume156,996
30 Day Avg. Volume165,284
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)1.09
Price to Sales (P/S)1.09
P/FCF Ratio30.53
Enterprise Value/Market Cap0.63
Enterprise Value/Revenue0.99
Enterprise Value/Gross Profit1.72
Enterprise Value/Ebitda8.61
Forecast
1Y Price Target
$8.10Price Target Upside48.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.18
Revenue Forecast (FY)$279.13M
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet / Net CashMaterialise's net cash position and large cash reserves provide durable financial flexibility. This supports investment in software/cloud transitions, buffers cyclical manufacturing demand, funds the buyback program, and reduces refinancing risk, underpinning multi‑quarter execution and strategic optionality.
High Recurring Software Revenue And Margin ImprovementA high and growing share of recurring software revenue shifts the mix toward predictable, higher‑margin income. Improved software adjusted EBITDA shows operating leverage from subscriptions and cloud adoption, strengthening long‑term cash flow visibility and scalability of profits.
Medical Segment Growth And Strategic Product LaunchesSustained medical growth and new device/planning launches expand a high‑value, less cyclical end market with regulatory barriers to entry. Patient‑specific implants and planning tools deepen clinical integration, supporting recurring procedure‑linked revenues and long‑term competitive moat.
Bears Say
Manufacturing Demand Cyclicality And Automotive ExposureMaterialise's manufacturing business remains exposed to cyclical prototyping and automotive spend. Lower utilization and program volatility can materially reduce volume‑based revenue and dilute fixed‑cost absorption, pressuring segment margins and cadence of earnings over several quarters.
Modest And Volatile Free Cash Flow ConversionFCF is small and has swung between positive and negative periods, indicating uneven cash conversion. This limits sustained internal funding for capex, M&A, or dividends and increases reliance on cash reserves or buybacks for capital allocation, constraining long‑term financial flexibility.
Low Returns And Modest Net ProfitabilityLow net margins and returns on equity show limited earnings power relative to capital employed. Even with stable gross margins, modest operating leverage and top‑line softness constrain the company's ability to generate high, sustainable shareholder returns over the medium term.
Materialise News
MTLS FAQ
What was Materialise NV’s price range in the past 12 months?
Materialise NV lowest stock price was $4.78 and its highest was $7.00 in the past 12 months.
What is Materialise NV’s market cap?
Materialise NV’s market cap is $422.92M.
When is Materialise NV’s upcoming earnings report date?
Materialise NV’s upcoming earnings report date is Aug 27, 2026 which is in 51 days.
How were Materialise NV’s earnings last quarter?
Materialise NV released its earnings results on May 07, 2026. The company reported $0.034 earnings per share for the quarter, beating the consensus estimate of $0.011 by $0.023.
Is Materialise NV overvalued?
According to Wall Street analysts Materialise NV’s price is currently Undervalued.
Does Materialise NV pay dividends?
Materialise NV does not currently pay dividends.
What is Materialise NV’s EPS estimate?
Materialise NV’s EPS estimate is 0.05.
How many shares outstanding does Materialise NV have?
Materialise NV has 59,067,184 shares outstanding.
What happened to Materialise NV’s price movement after its last earnings report?
Materialise NV reported an EPS of $0.034 in its last earnings report, beating expectations of $0.011. Following the earnings report the stock price went down -3.203%.
Which hedge fund is a major shareholder of Materialise NV?
Currently, no hedge funds are holding shares in MTLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Materialise Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.10 (48.35% Upside)
$8.10 (48.35% Upside)
Blogger Sentiment
Bullish
MTLS Sentiment 70%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 48.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 20.4%
Last 30 Days ▲ 20.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.62%
12-Months-Change
Fundamentals
Return on Equity
4.13%
Trailing 12-Months
Asset Growth
14.33%
Trailing 12-Months
Company Description
Materialise NV
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
MTLS Company Deck
MTLS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial picture: revenue was stable despite FX headwinds, margins and adjusted profitability improved materially (adjusted EBITDA +>30%, adjusted EBIT up meaningfully), Medical reported solid growth with strategic product launches, software recurring revenue increased and software profitability improved, cash position strengthened, and sustainability and strategic portfolio actions were executed. Offsetting factors include FX-driven reported declines in some areas, an 8% YoY drop in Manufacturing revenue driven by softer prototyping and automotive demand, and the near‑term top‑line impact of divestments. On balance, the favorable profitability trends, cash generation, product and partnership momentum, and reaffirmed guidance outweigh the lowlights.View all MTLS earnings summariesMTLS Stock 12 Month Forecast
Average Price Target
$8.10
▲(48.35% Upside)
Technical Analysis
Ownership Overview
―
Insiders
0.11% Mutual Funds
7.44% Other Institutional Investors
91.59% Public Companies and
Individual Investors